Pentixapharm Holding AG (ETR:PTP)

Pentixapharm Holding AG Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jan 1, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Revenue	0.09	0.78	4.77	3.97	2.6
Other Revenue	0.43	1.27	1.74	-	0
Revenue	0.53	2.05	6.51	3.97	2.6
Revenue Growth (YoY)	-74.37%	-68.49%	64.04%	52.67%	-
Cost of Revenue	6.92	3.78	0.05	-	-
Gross Profit	-6.39	-1.73	6.46	3.97	2.6
Selling, General & Admin	6.89	2.26	2.29	1.26	1.13
Other Operating Expenses	2.85	3.34	10.11	4.77	3.01
Operating Expenses	13.47	24.68	12.55	6.14	4.24
Operating Income	-19.86	-26.41	-6.09	-2.17	-1.64
Interest Expense	-	-0.1	-0.18	-	-0
Interest & Investment Income	0.35	0.57	0.13	-	-
Earnings From Equity Investments	-	-	-	1.4	-0.09
Currency Exchange Gain (Loss)	-	0.01	-0.07	-0	-0
EBT Excluding Unusual Items	-19.51	-25.92	-6.21	-0.78	-1.73
Gain (Loss) on Sale of Assets	-	6.7	-	-	-
Other Unusual Items	-	1.72	-	-	-
Pretax Income	-19.51	-17.5	-6.21	-0.78	-1.73
Income Tax Expense	-3	-4.44	1.43	1.18	0.76
Net Income	-16.51	-13.06	-7.64	-1.96	-2.49
Net Income to Common	-16.51	-13.06	-7.64	-1.96	-2.49
Shares Outstanding (Basic)	25	25	22	-	-
Shares Outstanding (Diluted)	25	25	22	-	-
Shares Change (YoY)	-	14.21%	-	-	-
EPS (Basic)	-0.67	-0.53	-0.35	-	-
EPS (Diluted)	-0.67	-0.53	-0.35	-	-
Free Cash Flow	-18.6	-7.35	-2.81	-6.24	-4.1
Free Cash Flow Per Share	-0.75	-0.30	-0.13	-	-
Gross Margin	-	-84.26%	99.17%	100.00%	100.00%
Operating Margin	-3775.66%	-1286.53%	-93.49%	-54.70%	-63.09%
Profit Margin	-3138.97%	-636.25%	-117.27%	-49.38%	-95.81%
Free Cash Flow Margin	-3535.74%	-358.22%	-43.18%	-157.24%	-157.75%
EBITDA	-19.6	-26.34	-5.94	-2.06	-1.54
EBITDA Margin	-	-	-91.23%	-51.83%	-59.02%
D&A For EBITDA	0.26	0.07	0.15	0.11	0.11
EBIT	-19.86	-26.41	-6.09	-2.17	-1.64
EBIT Margin	-	-	-93.49%	-54.70%	-63.09%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.